𝔖 Scriptorium
✦   LIBER   ✦

πŸ“

Biological Flow in Large Vessels: Dialog Between Numerical Modeling and In Vitro/In Vivo Experiments

✍ Scribed by Jose-Maria Fullana, Claude Verdier, Valerie Deplano


Publisher
Wiley-ISTE
Year
2022
Tongue
English
Leaves
248
Series
Mechanics: Biomechanics
Category
Library

⬇  Acquire This Volume

No coin nor oath required. For personal study only.

✦ Synopsis


This book examines recent methods used for blood flow modeling and associated in vivo experiments, conducted using experimental data from medical imaging. Different strategies are proposed, from smallscale models to complex 3D modeling using modern computational codes. The geometries are wide-ranging and deal with the narrowing and widening of sections (stenoses, aneurysms), bifurcations, geometries associated with prosthetic elements, and even cases of vessels with smaller dimensions than those of the blood cells circulating in them.

Biological Flow in Large VesselsΒ provides answers to the question of how medical and biomechanical knowledge can be combined to address clinical problems. It offers guidance for further development of numerical models, as well as experimental protocols applied to clinical research, with tools that can be used in real-time and at the patient’s bedside, for decision-making support, predicting the progression of pathologies, and planning personalized interventions.

✦ Table of Contents


Cover
Half-Title Page
Title Page
Copyright Page
Contents
Preface
1 Hemodynamics and Hemorheology
1.1. Structure and function of the circulatory system
1.2. Blood composition
1.3. The red blood cell: structure and dynamics
1.3.1. Red blood cell properties
1.3.2. Erythrocyte pathologies
1.3.3. Red blood cell dynamics
1.4. Rheology and dynamics
1.4.1. Phenomenology of blood rheology
1.4.2. Red blood cell aggregation
1.4.3. Dynamics of microcirculation
1.5. Conclusion
1.6. References
2 CFD Analyses of Different Parameters Influencing the Hemodynamic Outcomes of Complex Aortic Endovascular Repair
2.1. Introduction
2.2. Methods
2.3. Results
2.3.1. Model without stenosis
2.3.2. Model with 40% diameter stenosis
2.3.3. Model with 70% diameter stenosis
2.4. Discussion
2.4.1. Velocity and flow
2.4.2. Pressure
2.4.3. TAWSS
2.4.4. PAS
2.4.5. Limitations
2.5. Conclusion
2.6. Acknowledgments
2.7. References
3 Vascular Geometric Singularities, Hemodynamic Markers and Pathologies
3.1. Introduction
3.2. General characteristics of blood flows at the macroscopic scale
3.3. Several geometric singularities of the cardiovascular system
3.3.1. Curvatures and bifurcations
3.3.2. Cross-section constriction
3.3.3. Cross-section enlargement
3.3.4. Valves
3.4. Hemodynamic markers
3.4.1. Indexes derived from wall shear stress
3.4.2. Indexes describing VSs
3.5. Correlation between hemodynamic markers and pathologies: some examples
3.5.1. WSS and pathologies
3.5.2. Hemodynamic markers and thrombus
3.6. Conclusion and perspectives
3.7. References
4 Role of Arterial Blood Flow in Atherosclerosis
4.1. Introduction
4.2. Role of arterial fluid mechanics in atherosclerosis
4.2.1. Atherosclerosis initiation and progression
4.2.2. Role of arterial flow in atherosclerosis
4.3. An illustrative example of the complexity of arterial flow fields: fluid dynamic interactions between two arterial branches
4.3.1. The specific problem addressed
4.3.2. Materials and methods
4.3.3. Results
4.3.4. Discussion
4.4. Concluding remarks
4.5. References
5 Patient-specific Hemodynamic Simulations: Model Parameterization from Clinical Data to Enable Intervention Planning
5.1. Introduction
5.2. Multiscale models: do we need patient-specific data?
5.2.1. Assessing function of a new procedure/device
5.2.2. Optimizing the procedure/device for an individual patient
5.2.3. Population studies
5.3. How do we include patient-specific data?
5.3.1. Type of clinical data available and associated challenges
5.3.2. Establishing if the resistance of the 3D part is negligible or not, and parameterization in case it is
5.3.3. Resistance of the 3D part is not negligible
5.4. When models fall short of expectations: toward adaptation
5.4.1. Liver hepatectomy and blood loss
5.4.2. Pulmonary stenosis alleviation and vascular adaptation
5.5. Conclusion
5.6. Acknowledgments
5.7. References
6 Reduced-order Models of Blood Flow: Application to Arterial Stenoses
6.1. Introduction
6.2. Blood flow modeling
6.2.1. Two-dimensional axisymmetric model
6.2.2. Multi-ring model
6.2.3. One-dimensional model
6.2.4. Zero-dimensional model
6.3. Validation of the models
6.3.1. The entry effect
6.3.2. The Womersley solution in an elastic artery
6.4. Application to arterial stenoses
6.5. Conclusion
6.6. References
7 YALES2BIO: A General Purpose Solver Dedicated to Blood Flows
7.1. Methods and validation
7.1.1. Food and Drug Administration case
7.1.2. Optical tweezers
7.1.3. Red blood cell self-organization
7.2. Simulation as support of modeling efforts
7.2.1. Single cell dynamics
7.2.2. Flow diverters
7.2.3. Echocardiography
7.3. Simulations for industrial applications
7.3.1. Flow in the Carmat artificial heart
7.3.2. Red blood cell dynamics in Horiba Medical’s blood analyzers
7.4. Current developments
7.4.1. Thrombosis
7.4.2. In Silico MRI
7.4.3. Multi-cells
7.5. Acknowledgments
7.6. References
8 Capsule Relaxation Under Flow in a Tube
8.1. Introduction
8.2. Overview of the physical problem
8.2.1. Fluid solver
8.2.2. Solid solver
8.2.3. Fluid–structure coupling by the IBM method
8.3. Transient flow of a microcapsule into a microfluidic channel with a step
8.3.1. Capsule flow in the Stokes regime
8.3.2. Relaxation dynamics in the Stokes regime
8.3.3. Relaxation dynamics in the Navier–Stokes regime
8.4. Discussion and conclusion
8.5. Acknowledgements
8.6. References
Conclusion: Words and Things
List of Authors
Index


πŸ“œ SIMILAR VOLUMES


Blood Flow in the Heart and Large Vessel
✍ Motoaki Sugawara (auth.), Motoaki Sugawara Ph.D., Fumihiko Kajiya M.D., Ph.D., A πŸ“‚ Library πŸ“… 1989 πŸ› Springer Tokyo 🌐 English

<p>Cardiovascular fluid mechanics is now used as a tool in determining diagnosis, treatment, and prognosis by physicians and surgeons working in the fields of cardiology and angiology. The text is based on a considerable amount of clinical and experimental data on blood flow in the heart and large v

Hepatotoxicity: From Genomics to In Vitr
✍ Dr Saura C. Sahu πŸ“‚ Library πŸ“… 2008 πŸ› Wiley 🌐 English

This book addresses all the current, up-to-date developments in this scientific discipline. Liver is the chief metabolizing site in the body, and thus, it is a major target organ for drug and chemical toxicity. Therefore, hepatotoxicity is an important endpoint in the safety evaluation of drugs and

Hepatotoxicity: From Genomics to In Vitr
✍ Saura Sahu πŸ“‚ Library πŸ“… 2008 🌐 English

This book addresses all the current, up-to-date developments in this scientific discipline. Liver is the chief metabolizing site in the body, and thus, it is a major target organ for drug and chemical toxicity. Therefore, hepatotoxicity is an important endpoint in the safety evaluation of drugs and

Biofluid Mechanics: Blood Flow in Large
✍ W. E. Stehbens, B. J. Martin (auth.), Dr.-Ing. habil. Dieter W. Liepsch (eds.) πŸ“‚ Library πŸ“… 1990 πŸ› Springer-Verlag Berlin Heidelberg 🌐 English

This book contains 87 papers of the 1989 Symposium on mechanical aspects of blood flow and cardiovascular disease. In the first section clinical studies deal with questions such as heart valve replacement surgical bypass techniques, ultrasound studies in humans and animals, the reaction of pharmaceu

Nanotoxicity: From In Vivo and In Vitro
✍ Daniel A. Casciano πŸ“‚ Library πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English

Nanomaterials - substances smaller than 100 nanometers in size - have been added in recent years to an increasing numbers of consumer products used in day-to-day life; in food packaging, medical devices, pharmaceuticals, cosmetics, odor-resistant textiles and household appliances. The extensive appl

Time Lags in Biological Models
✍ Norman MacDonald (auth.) πŸ“‚ Library πŸ“… 1978 πŸ› Springer-Verlag Berlin Heidelberg 🌐 English

<p>In many biological models it is necessary to allow the rates of change of the variables to depend on the past history, rather than only the current values, of the variables. The models may require discrete lags, with the use of delay-differential equations, or distributed lags, with the use of in